Learn how the late stage of diagnosis that is common with mantle cell lymphoma makes it harder to treat.

Drs Peter Martin and Eric Hsi have a thought-provoking discussion on key topics in the pathology of mantle cell lymphoma, including biopsies, diagnostic markers, and what the future holds for ...

A biopsy needs to be done, of the node or the bone marrow, and look for characteristic signatures of mantle cell lymphoma. It turns out that within these lymph nodes, there is a very characteristic ...

Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin’s lymphoma (NHL), a cancer that develops in the lymphatic system. The lymphatic system helps to protect the body from infection.

Mantle cell lymphoma is a cancer affecting the lymph nodes. Symptoms may include persistent lymph node swelling and pain that lasts more than 2 weeks.

Mantle cell lymphoma treatment offers options if patients relapse after CAR T-cell therapy, from bispecific antibodies, antibody drug conjugates, and other emerging therapies.

Mantle cell lymphoma (MCL) is a malignancy composed of cells that have normal counterparts found in the mantle zone of the lymph node, a thin area surrounding individual follicles. These cells ...

Find out how mantle cell lymphoma -- a type of non-Hodgkin's lymphoma -- differs from other lymphomas in things like where it starts, what causes it, how it grows, and what happens after treatment.

A lymph node biopsy is the main method of diagnosing both non-Hodgkin’s and Hodgkin’s lymphoma, including diffuse large B-cell lymphoma, which is the most common form of non-Hodgkin’s lymphoma.

Mantle cell lymphomas (MCLs) arise from immune cells called B cells, which make antibodies, in areas of lymph nodes known as "mantle zones." Most cases are diagnosed in men who are in their 60s or ...

Mantle cell lymphomas (MCLs) arise from immune cells called B cells, which make antibodies, in areas of lymph nodes known as "mantle zones." Most cases are diagnosed in men who are in their 60s or ...